摘要
目的：探讨原发性肝癌行肝动脉介入栓塞治疗的疗效及其临床价值.方法：收集我院124例原发性肝癌患者的临床资料,回顾性分析肝动脉介入栓塞治疗前后患者的肿瘤缩小率、血清AFP和生活质量的变化. 结果：原发性肝癌患者经肝动脉介入栓塞治疗后,肿瘤明显缩小;血清AFP明显降低,生活质量得到了改善（P〈0.05,P〈0.01）.结论：肝动脉介入栓塞治疗有助于缩小肿瘤的大小,降低AFP的水平,是不能手术切除的肝癌的首要措施.
Objective：To estimate efficacy and clinical value of transcatheter hepatic arterial chemoembolization of primary hepatocellular carcino- ma. Methods This retrospective research analyzed the results of 124 cases of primary hepatocellular carcinoma patients registered in our hospital. Tumor shrinkage rate, serum AFP and quality of life changes before and after transcatheter hepatic arterial ehemoembolization were analyzed. Results The transcatheter hepatic arterial chemoembolization treatment of patients with primary hepatocellular carcinoma, the tumor was significantly reduced; serum AFP was decreased and the quality of life had improved（ P d0.05, P d0.01）. Conclusion Transcatheter hepatic arterial ehemoembolization can help shrink the size of the tumor, lower the level of AFP,and it is the most important measures of unreseetable hepatocellular carcinoma.
关键词
原发性肝癌
介入栓塞
疗效
肝动脉
primary hepatoeellular earcinoma
Inervening Chemoembolization
Clinical Effectiveness
Hepatic Artery
